Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson’s disease
Metabotropic glutamate (mGlu) receptors are candidate drug targets for therapeutic intervention in Parkinson’s disease (PD). Here we focused on m…
Category: Parkinson’s disease